Stemson Therapeutics Raises $15M in Series A Funding
Stemson Therapeutics, a San Diego, CA-based pre-clinical stage cell therapy company, closed a $15m Series A financing.
The round was led by DCVC Bio with participation from Genoa Ventures, AbbVie Ventures and other investors. In addition, Kiersten Stead, Ph.D., Co-Managing Partner at DCVC Bio and Jenny Rooke, Ph.D., Managing Director at Genoa Ventures will join Stemson’s Executive Chairman Matt Posard and Chief Executive Officer and co-founder Geoff Hamilton on the board of directors.
The company intends to use the funds to advance development of its proprietary therapeutic solution to cure hair loss.
Stemson Therapeutics Secures $15M Series A Funding to Cure Hair Loss
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Novome Biotechnologies Appoints Dr David N Cook and Zachary Hornby to its Board of Directors
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.